A1BF9

1-[(1P)-5-bromo-2'-chloro[1,1'-biphenyl]-2-sulfonyl]-4-fluoro-N-[(2S)-4-(methanesulfonyl)butan-2-yl]piperidine-4-carboxamide

Created:	2024-11-06
Last modified:	2025-01-01

Find Related PDB Entry
1 entries where A1BF9 is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	62
Chiral Atom Count	1
Bond Count	64
Aromatic Bond Count	12

2D diagram of A1BF9

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-[(1P)-5-bromo-2'-chloro[1,1'-biphenyl]-2-sulfonyl]-4-fluoro-N-[(2S)-4-(methanesulfonyl)butan-2-yl]piperidine-4-carboxamide
Systematic Name (OpenEye OEToolkits)	1-[4-bromanyl-2-(2-chlorophenyl)phenyl]sulfonyl-4-fluoranyl-~{N}-[(2~{R})-4-methylsulfonylbutan-2-yl]piperidine-4-carboxamide
Formula	C₂₃ H₂₇ Br Cl F N₂ O₅ S₂
Molecular Weight	609.956
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	14.52	FC1(CCN(CC1)S(=O)(=O)c1ccc(Br)cc1c1ccccc1Cl)C(=O)NC(C)CCS(C)(=O)=O
SMILES	CACTVS	3.385	C[CH](CC[S](C)(=O)=O)NC(=O)C1(F)CCN(CC1)[S](=O)(=O)c2ccc(Br)cc2c3ccccc3Cl
SMILES	OpenEye OEToolkits	3.1.0.0	CC(CCS(=O)(=O)C)NC(=O)C1(CCN(CC1)S(=O)(=O)c2ccc(cc2c3ccccc3Cl)Br)F
Canonical SMILES	CACTVS	3.385	C[C@H](CC[S](C)(=O)=O)NC(=O)C1(F)CCN(CC1)[S](=O)(=O)c2ccc(Br)cc2c3ccccc3Cl
Canonical SMILES	OpenEye OEToolkits	3.1.0.0	C[C@H](CCS(=O)(=O)C)NC(=O)C1(CCN(CC1)S(=O)(=O)c2ccc(cc2c3ccccc3Cl)Br)F
InChI	InChI	1.06	InChI=1S/C23H27BrClFN2O5S2/c1-16(9-14-34(2,30)31)27-22(29)23(26)10-12-28(13-11-23)35(32,33)21-8-7-17(24)15-19(21)18-5-3-4-6-20(18)25/h3-8,15-16H,9-14H2,1-2H3,(H,27,29)/t16-/m0/s1
InChIKey	InChI	1.06	RBHNKTBCOAXEQK-INIZCTEOSA-N

Related Resource References

Resource Name	Reference
PubChem	177013927

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.